Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.

CONCLUSION: Mortality risk is significantly increased in NAFLD patients with long-term CKD due to metabolic comorbidities, not influenced by CKD per se. PMID: 30827925 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30827925?dopt=Abstract

Source: Clin Med Res - February 27, 2019 Category: Research Authors: Önnerhag K, Dreja K, Nilsson PM, Lindgren S Tags: Clin Res Hepatol Gastroenterol Source Type: research